Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

JNJ-17153656, a dual delta/mu opioid receptor agonist for GI disorders

Nov. 11, 2003

Chiron grants Vertex HCV license

Nov. 11, 2003

Pfizer patent covers new NS5B inhibitors with potential in HCV infection

Nov. 11, 2003

Edaravone has beneficial effects in LPS-induced liver damage

Nov. 10, 2003

Itopride reduces esophageal acid exposure in GERD

Nov. 7, 2003

Antiestrogen fulvestrant prevents gallstone formation

Nov. 7, 2003

DA-9601 provides high-quality ulcer healing in experimental rat model

Nov. 7, 2003

AZD-3582 associated with better intestinal tolerance compared to naproxen

Nov. 7, 2003

Viramidine heads for late-stage clinical testing

Nov. 7, 2003

Berna grants HBsAg rights to Dynavax

Nov. 6, 2003

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.